FIELD: medicine, orthopedics.
SUBSTANCE: the present innovation deals with treating osseous diseases caused by calcium exchange disorders. For this purpose certain calcium preparations should be reduced up to amorphous state to be perorally applied per 0.5-1.0 g, 2-4 times daily, at courses of not less than 10 d. The innovation provides efficient treatment due to high biodigestibility of amorphous calcium and its active accumulation in bony tissue.
EFFECT: higher efficiency of therapy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MECHANO-ACTIVATED AMORPHOUS AND AMORPHOUS-CRYSTALLINE CALCIUM SALTS OF GLUCONIC ACID, COMPOSITIONS, METHODS OF PRODUCTION, PHARMACEUTICAL PREPARATIONS AND METHOD OF TREATMENT BASED ON SAID PREPARATIONS | 2007 |
|
RU2373185C2 |
| CALCIUM GLUCONATE NANOSUBSTANCE SUPPOSITORIES FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY (VERSIONS) | 2012 |
|
RU2511649C1 |
| DENTAL PENCIL WITH CALCIUM GLUCONATE NANOSUBSTANCE FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY | 2012 |
|
RU2533264C2 |
| CALCIUM GLUCONATE NANOSUBSTANCE OINTMENT FOR TREATING SKIN DISEASES RELATED TO CALCIUM DEFICIENCY | 2012 |
|
RU2506071C1 |
| METHOD OF TREATING NEUROSIS | 2013 |
|
RU2582971C2 |
| METHOD FOR PREPARING BIOFUNCTIONAL NANOPARTICLE GRAFT | 2008 |
|
RU2367448C1 |
| METHOD FOR INCREASING BONE TISSUE MASS IN FRACTURE CASES | 1998 |
|
RU2155588C2 |
| METHOD OF CORRECTION OF METABOLISM IN OSTEAL TISSUE | 1992 |
|
RU2029550C1 |
| METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2804401C1 |
| METHOD OF INCREASING BONE MINERAL DENSITY IN PATIENTS WITH OSTEOPOROSIS AND POLYNEUROPATHY IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2799244C1 |
